Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

804
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
804
Peripheral Nervous System: Ganglia and Nerves01:24

Peripheral Nervous System: Ganglia and Nerves

1.7K
The Peripheral Nervous System (PNS) is a crucial component of the body's neural network, extending beyond the central nervous system (CNS) to bridge the gap between the CNS and the external environment. It encompasses nerves, ganglia, and sensory receptors.
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
1.7K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

512
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
512
Neural Regulation01:37

Neural Regulation

39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

252
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
252

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biallelic Nonsense Variants in NEFL May Cause a Non-Length-Dependent Neuropathy With Temporal Dispersion on Nerve Conduction Studies.

Journal of the peripheral nervous system : JPNS·2026
Same author

Motor Neuronopathy With Widespread Fasciculations in MCM3AP-Related Disorder: Clinical and Muscle MRI Insights.

Journal of the peripheral nervous system : JPNS·2026
Same author

Genetic and Clinical Spectrum of Hereditary Transthyretin Amyloidosis in Brazil.

Journal of the peripheral nervous system : JPNS·2026
Same author

Biallelic variants in ARHGAP19 cause a progressive inherited motor-predominant neuropathy.

The Journal of clinical investigation·2025
Same author

Electrophysiological findings in SH3TC2 neuropathy mimicking inflammatory neuropathies.

Journal of neurology, neurosurgery, and psychiatry·2025
Same author

Longitudinal Evaluation of Ataxia and Brain Structural Changes in RFC1-Related Disorder.

Movement disorders clinical practice·2025

Related Experiment Video

Updated: Jun 19, 2025

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.5K

Leprous neuropathy.

Wilson Marques1

  • 1School of Medicine of Ribeirão Preto, University of São Paulo Department of Neurosciences and Behavior Sciences, Ribeirão Preto, SP, Brazil.

Current Opinion in Neurology
|July 25, 2024
PubMed
Summary
This summary is machine-generated.

Early diagnosis and treatment of leprosy neuropathy are crucial to prevent nerve damage and disease spread. Recognizing leprosy as a neurological condition is key to the World Health Organization

More Related Videos

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

2.6K
Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

6.2K

Related Experiment Videos

Last Updated: Jun 19, 2025

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.5K
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

2.6K
Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

6.2K

Area of Science:

  • Neurology
  • Infectious Diseases
  • Dermatology

Background:

  • Leprosy remains a significant cause of neuropathy globally.
  • Delayed diagnosis frequently leads to severe and irreversible nerve impairment.

Purpose of the Study:

  • To emphasize the critical role of early diagnosis and treatment in managing leprosy neuropathy.
  • To highlight the neurological nature of leprosy as central to the World Health Organization's 'Leprosy Zero Action'.

Main Methods:

  • Clinical presentation analysis of leprosy neuropathy.
  • Diagnostic modalities including electromyography, high-resolution sonography, serology, and PCR.
  • Review of treatment protocols, including multidrug therapy.

Main Results:

  • Leprosy neuropathy typically presents as a mononeuropathy or multiple mononeuropathy.
  • Nerve involvement often exhibits a temperature-dependent distribution.
  • Diagnostic tools aid in identifying the condition and guiding treatment.

Conclusions:

  • Prompt diagnosis and initiation of multidrug therapy are essential to prevent disability and transmission.
  • Understanding leprosy as a neurological disease is fundamental for effective control strategies.
  • Early intervention is key to improving patient outcomes and achieving leprosy elimination goals.